Literature DB >> 11024083

BOLD fMRI response of early visual areas to perceived contrast in human amblyopia.

B G Goodyear1, D A Nicolle, G K Humphrey, R S Menon.   

Abstract

In this study, we used a temporal two-alternative forced choice psychophysical procedure to measure the observer's perception of a 22% physical contrast grating for each eye as a function of spatial frequency in four subjects with unilateral amblyopia and in six subjects with normal vision. Contrast thresholds were also measured using a standard staircase method. Additionally, blood-oxygenation-level-dependent (BOLD) functional magnetic resonance imaging (fMRI) was used to measure the neuronal response within early visual cortical areas to monocular presentations of the same 22% physical contrast gratings as a function of spatial frequency. For all six subjects with normal vision and for three subjects with amblyopia, the psychophysically measured perception of 22% contrast as a function of spatial frequency was the same for both eyes. Threshold contrast, however, was elevated for the amblyopic eye for all subjects, as expected. The magnitude of the fMRI response to 22% physical contrast within "activated" voxels was the same for each eye as a function of spatial frequency, regardless of the presence of amblyopia. However, there were always fewer "activated" fMRI voxels during amblyopic stimulation than during normal eye stimulation. These results are consistent with the hypotheses that contrast thresholds are elevated in amblyopia because fewer neurons are responsive during amblyopic stimulation, and that the average firing rate of the responsive neurons, which reflects the perception of contrast, is unaffected in amblyopia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024083     DOI: 10.1152/jn.2000.84.4.1907

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  31 in total

1.  Responses of human visual cortex to uniform surfaces.

Authors:  John-Dylan Haynes; R Beau Lotto; Geraint Rees
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

2.  Monocular activation of V1 and V2 in amblyopic adults measured with functional magnetic resonance imaging.

Authors:  Ian P Conner; J Vernon Odom; Terry L Schwartz; Janine D Mendola
Journal:  J AAPOS       Date:  2007-04-16       Impact factor: 1.220

3.  Retinotopic maps and foveal suppression in the visual cortex of amblyopic adults.

Authors:  Ian P Conner; J Vernon Odom; Terry L Schwartz; Janine D Mendola
Journal:  J Physiol       Date:  2007-07-12       Impact factor: 5.182

Review 4.  Linking assumptions in amblyopia.

Authors:  Dennis M Levi
Journal:  Vis Neurosci       Date:  2013-07-24       Impact factor: 3.241

5.  Differential activation of cerebral blood flow by stimulating amblyopic and fellow eye.

Authors:  Shoichi Mizoguchi; Yukihisa Suzuki; Motohiro Kiyosawa; Manabu Mochizuki; Kenji Ishii
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-01-14       Impact factor: 3.117

6.  The use of the scanning laser ophthalmoscope in the evaluation of amblyopia (an American Ophthalmological Society thesis).

Authors:  David A Johnson
Journal:  Trans Am Ophthalmol Soc       Date:  2006

7.  Rethinking amblyopia 2020.

Authors:  Dennis M Levi
Journal:  Vision Res       Date:  2020-08-28       Impact factor: 1.886

8.  Functional magnetic resonance imaging (fMRI) and effects of L-dopa on visual function in normal and amblyopic subjects.

Authors:  Gary L Rogers
Journal:  Trans Am Ophthalmol Soc       Date:  2003

9.  Correlation of the measurements of optical coherence tomography and diffuse tension imaging of optic pathways in amblyopia.

Authors:  Özgül Altıntaş; Sevtap Gümüştaş; Ruken Cinik; Yonca Anık; Berna Özkan; Levent Karabaş
Journal:  Int Ophthalmol       Date:  2016-04-11       Impact factor: 2.031

10.  [Visual cortex in the Tolosa-Hunt syndrome. Functional imaging for the detection of a psychogenic disorder--a case report].

Authors:  B Pleger; A-F Förster; P Schwenkreis; V Nicolas; J-P Malin; J Frettlöh; C Maier; M Tegenthoff
Journal:  Schmerz       Date:  2004-06       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.